Relmada Therapeutics, Inc. (RLMD)

7.48 +0.48 (+6.86%) USD  |  NASDAQ  |  Apr 17, 16:00
7.47 -0.01 (-0.13%) After-Hours: 20:00
More

Relmada Therapeutics Revenue Per Employee (Annual)

Revenue Per Employee (Annual) Chart

View Revenue Per Employee (Annual) for RLMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Per Employee (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Per Employee (Annual) Range, Past 5 Years

View Revenue Per Employee (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Per Employee (Annual) Benchmarks

View Revenue Per Employee (Annual) Benchmarks
Start Trial
Catalyst Pharmaceuticals, Inc. Upgrade
Theravance Biopharma, Inc. Upgrade
Avalo Therapeutics, Inc. Upgrade
AN2 Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade